Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Hydronephrosis

paclitaxel has been researched along with Hydronephrosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Khan, SA; Parajuli, SB; Rayamajhi, A; Sah, S; Sapkota, S1
Faggioni, L; Gadducci, A; Manassero, F; Selli, C; Tognarelli, A1
Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Sakita, I; Souma, I; Yoshida, T1
Dewan, P; Lin, DW; Montgomery, RB; Wright, JL1
Hirakawa, K; Inoue, T; Kim, T; Kimura, K; Muguruma, K; Ohira, M; Sawada, T; Toyokawa, T; Yamashita, Y; Yashiro, M1
Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N1

Other Studies

6 other study(ies) available for paclitaxel and Hydronephrosis

ArticleYear
Promising Response of Paclitaxel in Metastatic Transitional Cell Carcinoma of Distal Ureter Complicated with Hydroureteronephrosis: A Case Report.
    JNMA; journal of the Nepal Medical Association, 2023, Mar-01, Volume: 61, Issue:259

    Topics: Aged; Carcinoma, Transitional Cell; Female; Humans; Hydronephrosis; Lung Neoplasms; Paclitaxel; Renal Insufficiency; Ureter; Ureteral Neoplasms

2023
A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab.
    BMC urology, 2019, Dec-09, Volume: 19, Issue:1

    Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Foreign-Body Migration; Humans; Hydronephrosis; Neoplasm Recurrence, Local; Paclitaxel; Rectum; Stents; Ureter; Urinary Bladder Fistula; Urinary Tract Infections; Uterine Cervical Neoplasms

2019
[A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Combinations; Female; Gastrectomy; Humans; Hydronephrosis; Lymph Node Excision; Neoplasm Recurrence, Local; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Peritonitis; Pyridines; Stents; Stomach Neoplasms; Tegafur

2004
Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.
    International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Bone Marrow Neoplasms; Bone Neoplasms; Hematuria; Humans; Hydronephrosis; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Renal Dialysis; Renal Insufficiency; Tumor Lysis Syndrome

2005
[A case of advanced gastric cancer with malignant ascites responding to weekly paclitaxel therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:11

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Agents, Phytogenic; Ascites; Drug Administration Schedule; Female; Humans; Hydronephrosis; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms

2006
Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2007, Volume: 10, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Hydronephrosis; Infusions, Parenteral; Liver Neoplasms; Male; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur

2007